Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Biomerica, Inc. (BMRA : NSDQ)
 
 • Company Description   
BIOMERICA, INC. is an emerging-growth biotechnology firm that develops, manufactures and distributes medical diagnostic products. The Company is focused on niche products for early detection and monitoring of human diseases and conditions before they become catastrophic and incurable. The customers include medical universities, pharmaceutical companies, hospitals, clinics, commercial laboratories, physician's offices and consumers.

Number of Employees: 64

 
 • Price / Volume Information   
Yesterday's Closing Price: $3.34 Daily Weekly Monthly
20 Day Moving Average: 67,042 shares
Shares Outstanding: 2.55 (millions)
Market Capitalization: $8.50 (millions)
Beta: 0.35
52 Week High: $8.80
52 Week Low: $1.93
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.60% -3.17%
12 Week -13.04% -26.85%
Year To Date 39.12% 30.29%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
17571 Von Karman Avenue
-
Irvine,CA 92614
USA		 ph: 949-645-2111
fax: 949-553-1231		 investors@biomerica.com http://www.biomerica.com
 
 • General Corporate Information   
Officers
Zackary S. Irani - Director; Chief Executive Officer
Allen Barbieri - Director; Vice-Chairman
Gary Lu - Chief Financial Officer
Jane Emerson - Director
David Moatazedi - Director

Peer Information
Biomerica, Inc. (GSAC)
Biomerica, Inc. (CASI)
Biomerica, Inc. (ALCD.)
Biomerica, Inc. (OMNN)
Biomerica, Inc. (CGPI.)
Biomerica, Inc. (CATX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 09061H406
SIC: 2835
Fiscal Year
Fiscal Year End: May
Last Reported Quarter: 02/01/25
Next Expected EPS Date: 08/27/25
Share - Related Items
Shares Outstanding: 2.55
Most Recent Split Date: 4.00 (0.13:1)
Beta: 0.35
Market Capitalization: $8.50 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/27/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.54
Price/Cash Flow: -
Price / Sales: 1.50
EPS Growth
vs. Year Ago Period: 45.45%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: 10.03%
vs. Previous Quarter: -31.60%
ROE
05/31/25 - -
02/28/25 - -85.90
11/30/24 - -90.19
ROA
05/31/25 - -
02/28/25 - -61.06
11/30/24 - -64.54
Current Ratio
05/31/25 - -
02/28/25 - 3.76
11/30/24 - 3.17
Quick Ratio
05/31/25 - -
02/28/25 - 2.76
11/30/24 - 2.22
Operating Margin
05/31/25 - -
02/28/25 - -85.42
11/30/24 - -100.52
Net Margin
05/31/25 - -
02/28/25 - -85.42
11/30/24 - -100.52
Pre-Tax Margin
05/31/25 - -
02/28/25 - -85.35
11/30/24 - -100.31
Book Value
05/31/25 - -
02/28/25 - 2.17
11/30/24 - 2.43
Inventory Turnover
05/31/25 - -
02/28/25 - 2.53
11/30/24 - 2.42
Debt-to-Equity
05/31/25 - -
02/28/25 - 0.00
11/30/24 - 0.00
Debt-to-Capital
05/31/25 - -
02/28/25 - 0.00
11/30/24 - 0.00
 

Powered by Zacks Investment Research ©